Topic search: STERILE PREPARATIONS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Sterile Preparations Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2025 Pg. 489-490	Albuterol Sulfate 1 mg/mL and Ipratropium Bromide 0.2 mg/mL Sterile Inhalation Solution, Preservative -Free Author(s):
Nov/Dec 2025 Pg. 493	Bacitracin 500 Units/gram Sterile Ophthalmic Ointment Author(s):
Sep/Oct 2025 Pg. 337-343	Immediate Use Compounding Sterile Products (CSP)- Need of Alternative Sterility Testing Method- A Review Author(s): Rajagopal Kumaravelrajan, Venkatesan Suba
Sep/Oct 2025 Pg. 367-370	Sterile Compounding: Strengthening PEC and C-PEC Compliance Author(s): Wasescha David
May/Jun 2025 Pg. 194-201	Microbial Challenge of Stable Compounded Clozapine Suspensions in Plastic Bottles Author(s): Berzy Jessica, Sachedina Hanif, Virji Arif, Gross Jason A, Cull Erica, Walker Scott E
Mar/Apr 2025 Pg. 116-119	New USP Chapters <72> and <86> for Testing Pharmaceuticals for Sterility and Endotoxins Author(s): Ashworth Lisa D
Jan/Feb 2025 Pg. 38-39	Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Author(s):
Nov/Dec 2024 Pg. 475-479	Hand and Glove Sanitizing in Sterile Compounding, Part 1 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2024 Pg. 358-362	Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 383-393	Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Author(s): Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jul/Aug 2024 Pg. 298-303	Sterile Basics of Compounding: Repackaging, Part 1 Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 229-240	Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Author(s): Akers Michael J
Mar/Apr 2024 Pg. 120-127	Sterile Filtration Author(s): Akers Michael J
Jan/Feb 2024 Pg. 44-55	Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Author(s): Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Nov/Dec 2023 Pg. 483-486	Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 491	Hyaluronidase Injection Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 397-409	Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 305-313	Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 223-229	Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 114-121	Advanced Compounding; How to Investigate Microbiological Excursions at a Sterile Compounding Facility Author(s): Summers Amy
Mar/Apr 2023 Pg. 123-139	Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 142	Aminohippurate Sodium 250 mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 154-159	Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes Author(s): de Wilde Sofieke, Crul Mirjam, Breukels Oscar
Jan/Feb 2023 Pg. 39-46	Sterile Basics: How to Know if Your Cleanroom Can Consistently Operate Within a State of Control Author(s): Summers Amy, Stephens Pat
Nov/Dec 2022 Pg. 497-504	Sterile Basics of Compounding: Contamination Control Strategies, Part 2 Author(s): Summers Amy
Nov/Dec 2022 Pg. 515	Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding) Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 411-418	Sterile Basics of Compounding: Contamination Control Strategies, Part 1 Author(s): Summers Amy
Jul/Aug 2022 Pg. 309-315	Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program Author(s): Summers Amy
May/Jun 2022 Pg. 211-213	Three Things You Need to Know Right Now Author(s): Brunner Scott
May/Jun 2022 Pg. 219-228	Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 248-254	Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine Author(s): Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
Mar/Apr 2022 Pg. 118-126	Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 129-136	Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 10-17	Pharmacy Student Satisfaction and Perceptions Following a Virtual Sterile Compounding Experience Author(s): Mohammad Insaf, Lobkovich Alison, Nardolillo Joseph, Wilhelm Shelia
Jan/Feb 2022 Pg. 41-49	Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 446-462	Microwave Freeze-thaw Technique for Injectable Drugs: A Review Updated from 1980 to 2021 Author(s): Hecq Jean-Daniel, Soumoy Laura, Closset Mélanie, Colsoul Marie-Lise, Jamart Jacques, Galanti Laurence
Nov/Dec 2021 Pg. 491-496	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 389-395	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Jul/Aug 2021 Pg. 276-281	Expecting the Expected: Planning Considerations for Cleanroom Construction Author(s): Roberts Patricia A, Kroon Laura
Jul/Aug 2021 Pg. 298-302	Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 1 Author(s): Higgins Doral (Neal) O, Prudom Melanie J, Summers Amy
Jul/Aug 2021 Pg. 311-317	Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 182-186	Pharmacy Technicians' Perceptions of Risk Reduction Strategies Implemented in Response to the Repetitive Strain Injury Associated with Sterile Compounding Author(s): Zamani Mazdak, Chan Kayin, Wilcox Julie
May/Jun 2021 Pg. 222-229	Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 92	PreScription: The Past (-->2020), The Present, and The Future (2021-->) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 109-113	Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic Author(s): Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
Mar/Apr 2021 Pg. 131-139	Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 18-23	Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol Author(s): McKettrick Greg, Yoch Doug
Jan/Feb 2021 Pg. 42	Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 460-465	Establishing a Structured Pharmacy Training Program in Sterile Compounding Author(s): Dirbas Muhannad, AbuSara Aseel K, Whiyabi Shatha, Harb Rema, Telfah Shorouq
Nov/Dec 2020 Pg. 473-478	Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 358-364	Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients Author(s): Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
Sep/Oct 2020 Pg. 406	Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 434-438	Evaluation of the Efficacy and Superiority of Different Vial Rubber Closure Disinfection Techniques Author(s): Bjornstad Matthew, Kosinski Tracy, Burlage Robert
Jul/Aug 2020 Pg. 299-303	Quality Control: Rapid Sterility Testing for Compounding Pharmacies Author(s): Taylor Andrew
Jul/Aug 2020 Pg. 305-309	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 346-351	Single Center Experience with Robot Technologies for Sterile Compounding: A Retrospective Review Author(s): Milibari Loay, Cotugno Michael, Belisle Caryn, Rocchio Megan, Patterson Robert F, Chacon Pablo, Fanikos John, Vo Peter
May/Jun 2020 Pg. 215-220	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 121-126	Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 14-19	How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Author(s): Vaughn Stacey R, Radwick Allison
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 447-452	Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators Author(s): Mulder Kyle
Nov/Dec 2019 Pg. 454-461	How to Qualify Container Closure Systems for Intended Use, Part 1 Author(s): Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
Nov/Dec 2019 Pg. 467-471	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 2 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Nov/Dec 2019 Pg. 478-482	Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 387-391	Quality Control: Hand and Glove Sanitizing in Sterile Compounding, Part 1 Author(s): Greeson Nicole MH, Mixon William, Huslage Kirk, Stiegel Matthew A, Thomann Wayne R
Sep/Oct 2019 Pg. 399-402	Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 299-303	Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 221-228	Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 238-244	Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website Author(s): Sluggett Janet K, Johnson Michelle J, Zamani Mazdak, Kastango Eric S, Bodnar Mark, Cantor Peter, Hobbs Jodie G, Reynolds Karen J, Sluggett Andrew J
Mar/Apr 2019 Pg. 123-130	Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 47-49	Quality Control and Basics of Sterile Compounding: Attempting to Avoid Out-of-Specification Results and Patient Harm in Sterile Compounding Author(s): Martin Matt
Nov/Dec 2018 Pg. 475-478	Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2 Author(s): Martin Matt
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Sep/Oct 2018 Pg. 401-404	Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1 Author(s): Martin Matt
Sep/Oct 2018 Pg. 408	Cysteamine 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 303-312	Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Author(s): Martin Matt
May/Jun 2018 Pg. 206-217	Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 234	Dorzolamide 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 129-134	Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Author(s): Rhoads Rick
Mar/Apr 2018 Pg. 147	Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 151	Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 41-46	Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy Author(s): Kosinski Tracy M, Brown Michael C, Zavala Pedro J
Jan/Feb 2018 Pg. 50	Glutamate and Aspartate Cardioplegia Additive Solution Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 493	Haloperidol 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 498	Trace Elements Injection 5 Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 499	Vancomycin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 395-404	Basics of Sterile Compounding: Particulate Matter Author(s): Akers Michael J
Sep/Oct 2017 Pg. 408	Acetylcysteine Solutions for Inhalation Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 410	Etoposide 20-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 411	Fentanyl Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 413	Ioversol Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 415	Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 426-429	Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes Author(s): Kirkham Kylian, Munson Jessica M, McCluskey Susan V, Graner Kevin K
Sep/Oct 2017 Pg. 436-439	Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Author(s): Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
Jul/Aug 2017 Pg. 277-280	Component Selection for Sterile Compounding Author(s): Dilzer Richard H
Jul/Aug 2017 Pg. 301-308	Basics of Sterile Compounding: Excipients Used in Injections Author(s): Akers Michael J
Jul/Aug 2017 Pg. 317	Reteplase Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 319	Tacrolimus 0.06% Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 320	Torsemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 182-190	Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding Author(s): Ligugnana Roberto
May/Jun 2017 Pg. 193-203	Microbiologic Testing for 503A Sterile-Compounding Pharmacies Author(s): Mixon William, Roth Abby
May/Jun 2017 Pg. 223-228	Basics of Sterile Compounding: Manipulating Peptides and Proteins Author(s): Akers Michael J
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Mar/Apr 2017 Pg. 133-142	Accuracy Considerations in Sterile Compounding Author(s): Akers Michael J
Mar/Apr 2017 Pg. 150-153	Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers Author(s): McCluskey Susan V, Kirkham Kylian, Munson Jessica M
Jan/Feb 2017 Pg. 47-56	Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Author(s): Akers Michael J
Jan/Feb 2017 Pg. 62	Infliximab 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 64	Tetracaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 509	Flumazenil 0.1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 408	Inamrinone 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 415	Tromethamine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 283-292	Choosing a Vial Processing Line for Aseptic Compounding: Part 1 Author(s): Noorian Shaun, Vahedi Navid
Jul/Aug 2016 Pg. 307-314	Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding Author(s): Akers Michael J
Jul/Aug 2016 Pg. 318	Dolasetron Mesylate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 319	Gatifloxacin 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 325	Plasmingen and Hyaluronate Sodium Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 326	Scopolamine Hydrobromide 0.25% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 217-222	Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration Author(s): Akers Michael J
May/Jun 2016 Pg. 226	Carboplatin 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 227	Cefotetan Disodium Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 228	Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 234	Sodium Nitroprusside 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 99-104	Root Cause Analysis, Part 2: Sterile Compounding Author(s): Cabaleiro Joe, Jackson Kathleen
Jan/Feb 2016 Pg. 41-45	Formulation and Stability of Solutions Author(s): Akers Michael J
Jan/Feb 2016 Pg. 51	Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 54	Thrombin 1,000 Units/mL Topical Solution, Sterile Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 55	Tropicamide 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 56	Vancomycin 5% and Amikacin 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 491-500	Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Author(s): Akers Michael J
Nov/Dec 2015 Pg. 505	Cefepime Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 506	Cefotaxime 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 507	Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 509	Estradiol Valerate 40-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 510	Levetiracetam 100-mg/mL Injection (Concentrate) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 383-386	Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Author(s): Donnelly Ronald F
Sep/Oct 2015 Pg. 393-401	Sterile Filtration Author(s): Akers Michael J
Jul/Aug 2015 Pg. 268-278	Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Author(s): Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
Jul/Aug 2015 Pg. 315-320	Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Author(s): Akers Michael J
Jul/Aug 2015 Pg. 324	Ammonium Molybdate 25-mcg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 328	Cytarabine 50-mg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 329	Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 330	Oxytocin 10-units/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 331	Phytonadione 2-mg/mL Injection Author(s): Allen Loyd V
May/Jun 2015 Pg. 182-192	Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities Author(s): Weller Tom, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan
May/Jun 2015 Pg. 215-221	Quality Assurance and Quality Control, Part 2 Author(s): Akers Michael J
May/Jun 2015 Pg. 232-238	Basics of Sterile Compounding: Contamination Control Author(s): Akers Michael J
May/Jun 2015 Pg. 246	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 247	Scopolamine Hydrobromide -.4-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 252-260	Protocol of Blood Serum Eye Drops Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
May/Jun 2015 Pg. 261-267	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Author(s): Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
Mar/Apr 2015 Pg. 94-102	New England Compounding Center Indictment Author(s): Cabaleiro Joe
Mar/Apr 2015 Pg. 121-124	Quality Assurance and Quality Control, Part 1 Author(s): Akers Michael J
Mar/Apr 2015 Pg. 127-138	Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Author(s): Akers Michael J
Mar/Apr 2015 Pg. 143	Aminohippurate Sodium 200-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 146	L-Cysteine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 147	Morrhuate Sodium 5% Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 149	Pancuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 150	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 151	Trypan Blue 0.06% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 49-56	Basics of Sterile Compounding: Aseptic Processing Author(s): Akers Michael J
Jan/Feb 2015 Pg. 62	Cisplatin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 63	Daunorubicin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 64	Erythromycin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 65	Hydralazine Hydrochloride 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 69	Phentolamine Mesylate 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 444	PreScription: "Named Formulas" Database Available Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 446-454	Depyrogenation Options for the Compounding Cleanroom Author(s): Weller Tom, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
Nov/Dec 2014 Pg. 479-484	Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms Author(s): Akers Michael J
Nov/Dec 2014 Pg. 495	Dexmedetomidine 100 mcg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 497	Leucovorin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 498	Levocarnitine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 500	Methylene Blue 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 502	Oxacillin Sodium 167-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Sep/Oct 2014 Pg. 397-399	Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know Author(s): Lanze Amanda, Rudner Shara
Sep/Oct 2014 Pg. 408	Azithromycin 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 410	Dexpanthenol 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 412	Fluorescein 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 413	Indocyanine green 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 270-276	Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety Author(s): Johnson Kain, Sully Andrew, Anthenat Bruce
Jul/Aug 2014 Pg. 313-317	Basics of Compounding Sterile Preparations: Nomenclature and Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 322	Atracurium Besylate 10-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 324	Calcitriol 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 325	Chloramphenicol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 329	Indigo Carmine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 330	Propranolol Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 331	Zinc 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 234	Bupivacaine Hydrochloride 0.5% Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 237	Lidocaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 94-99	A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards Author(s): Marks Zach
Mar/Apr 2014 Pg. 123-130	Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Author(s): Vu Nicole, Nguyen Devin, Kupiec Thomas C
Mar/Apr 2014 Pg. 131-134	Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 143	Fludarabine Phosphate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 144	Mecasermin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 145	Methylprednisolone 40-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 146	Polymixin B Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 147	Rocuronium Bromide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 149	Selenium 40-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 150	Sincalide 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 151	Testosterone Enanthate 200-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014 Pg. 30-34	Determination of Risk for Sterile Preparations Author(s): Freedman ben-Horin Shimon, Rousso Tamaro
Jan/Feb 2014 Pg. 46-52	Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding Author(s): Hyde Tiffany D
Jan/Feb 2014 Pg. 54-57	Basics of Sterile Compounding: Bubble Point Testing Author(s): Thoma Laura
Jan/Feb 2014 Pg. 60	Aztreonam Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 61	Bumetanide 0.25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 62	Droperidol 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 67	Potassium Chloride 2-mEq/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 68	Procainamide Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 69	Vasopressin 20-units/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 465-475	Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies Author(s): Brensel Robert, Brensel Scott, Ng Amy
Nov/Dec 2013 Pg. 498	Benztropine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 499	Cefazolin 250-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 502	Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 503	Dihydroergotamine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 358-362	Compounding Pharmacies: Before and After an Inspection Author(s): Kulkarni Darshan, Ricketts Samantha
Sep/Oct 2013 Pg. 414	Acyclovir 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 415	Aminocaproic Acid 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 416	Clindamycin 150-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 417	Fluorouracil 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 418	Hydroxyzine Hydrochloride 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 420	Mesna 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 421	Methotrexate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 422	Phenylephrine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 423	Terbutaline Sulfate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 283-288	United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013 Author(s): Newton David W
Jul/Aug 2013 Pg. 307-311	Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Author(s): McElhiney Linda F
Jul/Aug 2013 Pg. 328	Allopurinol Sodium 4-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 329	Amikacin Sulfate 250-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 330	Dacarbazine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 331	Ketamine 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 332	Methohexital Sodium 500-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 333	Metoprolol Tartrate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 335	Succinylcholine Chloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 193-199	Decontamination Technology: The Missing Element Author(s): Rahe Hank
May/Jun 2013 Pg. 238-246	Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Mar/Apr 2013 Pg. 94-98	Sterilization of Compounded Parenteral Products: Verification of Autoclaves Author(s): Rahe Hank
Mar/Apr 2013 Pg. 130-134	Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program Author(s): Griffiths Tricia, Connors Anne
Mar/Apr 2013 Pg. 136-140	Basics of Compounding: Repackaging, Part 2 Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 144	Adenosine 3-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 145	Alcohol Dehydrated Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 147	Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 148	Cyanocobalamin 1000-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 149	Dexrazoxane 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 150	Meropenem 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 151	Paclitaxel 6-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 152	Thiotepa 15-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 168-174	Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings Author(s): Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
Jan/Feb 2013 Pg. 54-60	Basics of Compounding: Repackaging, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 64	Desmopressin 4-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 65	Dobutamine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 67	Ibuprofen 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 68	Mepivacaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 69	Milrinone 0.2-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 70	Neostigmine Methylsulfate 0.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 71	Nicardipine Hydrochloride Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 72	Octreotide 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 73	Testosterone Cypionate 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 500	Aminophylline 25-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 501	Ammonium Chloride 5-mEq/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 502	Azathioprine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 503	Copper 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 504	Dipyridamole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 505	Dopamine Hydrochloride 80-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 506	Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 507	Papaverine Hydrochloride 30-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 508	Valproate Sodium 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 509	Vercuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 425	Metronidazole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 418	Doxapram Hydrochloride 20-mg/mL injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 419	Enalaprilat 1.25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 420	Esmolol Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 421	Fluconazole 2-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 422	Haloperidol 50-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 423	Meperidine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 424	Methocarbamol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 426	Nalbuphine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 427	Oxymorphone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 190-195	I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease Author(s): McElhiney Linda F
Jan/Feb 2012 Pg. 86-87	PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone Author(s): Cabaleiro Joe
Jan/Feb 2012 Pg. 6-10	Misinterpretation of United States Pharmacopeia Chapter <797> Author(s): McElhiney Linda F
Sep/Oct 2011 Pg. 390-407	Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons Author(s): James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
May/Jun 2011 Pg. 224-232	Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions Author(s): Schnatz Rick, Hernandex-Cardoso Antonio
Mar/Apr 2011 Pg. 133-144	Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 Author(s): Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug
Jan/Feb 2011 Pg. 4	PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals Author(s): Allen Loyd V Jr, Menighan Thomas E
Jan/Feb 2011 Pg. 20-26	A Technology Guide for Evaluating Software Tools to Support Sterile Compounding and Workflow Management Author(s): Robinson Marian
Jan/Feb 2011 Pg. 49-54	Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 3: A Simplified Endotoxin Test Method for Compounded Sterile Preparations Author(s): Cooper James F
Nov/Dec 2010 Pg. 493-506	Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2 Author(s): Cooper James F, Chakrabarty Kaushik, McGuire Jason, Zolner William J, Jones Vann, Hedman Hilary
Nov/Dec 2010 Pg. 450-455	Home Infusion: Overcoming the Barriers to Entry Author(s): Franklin David M
Sep/Oct 2010 Pg. 370-372	Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device Author(s): Kennedy Steve, Siefert Lisa Linn, Lange Matt
Sep/Oct 2010 Pg. 407-414	Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 Author(s): Dubczak John, Latta Kenneth S, Hedman Hilary, Smith Donald R
Sep/Oct 2010 Pg. 440-441	PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board Author(s): Pharmacy Compounding Accreditation Board
Jul/Aug 2010 Pg. 268	PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals Author(s): Menighan Thomas E
Jul/Aug 2010 Pg. 270-274	Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Author(s): McElhiney Linda F
Jul/Aug 2010 Pg. 317-320	Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters Author(s): Dawson Michael E
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr
May/Jun 2010 Pg. 232-238	Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Author(s): Okeke Claudia C, Allen Loyd V Jr
Mar/Apr 2010 Pg. 142-149	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2010 Pg. 160-164	Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector Author(s): Khondkar Dristi, Chopra Poonam, McArter John P, Rosen Joseph A, Li S Kevin
Jan/Feb 2010 Pg. 70	Ophthalmic Toning-Lubricating Drops Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 48-53	An Academic Practice Partnership: An Innovative Course in Advanced Compounding Author(s): Hale Katherine S, Hammer Dana P, Needham Shawn, Lawhorn Michelle Gaster
Jan/Feb 2010 Pg. 60-64	Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control Author(s): Okeke Claudia C, Allen Loyd V Jr
Nov/Dec 2009 Pg. 506-515	Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Nov/Dec 2009 Pg. 540-543	Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Author(s): Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Nov/Dec 2009 Pg. 546-553	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures Author(s): Okeke Claudia C, Allen Loyd V Jr
Nov/Dec 2009 Pg. 564-568	Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Author(s): Bailey Caroline, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole
Sep/Oct 2009 Pg. 420-426	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2009 Pg. 290-294	Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Author(s): Mixon Bill, Ille Gary
Jul/Aug 2009 Pg. 322-329	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2009 Pg. 350-351	PostScription: Compounding Pharmacy in Puerto Rico Author(s): Lopez Marisol
Jul/Aug 2009 Pg. 300-310	Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting Author(s): McElhiney Linda F
May/Jun 2009 Pg. 234-238	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2009 Pg. 94-98	Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797> Author(s): McElhiney Linda F
Mar/Apr 2009 Pg. 100-104	Tips for Cleanroom Construction and Renovation Author(s): Mixon William, Huffman Lanny
Mar/Apr 2009 Pg. 106-119	Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations Author(s): Latta Kenneth S, Howard Betty, Gordon Ken, Foster Lisa, Nichols Larry, Floyd Dan B, Winters Martell, Bryans Trabue
Mar/Apr 2009 Pg. 146-150	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2009 Pg. 152	Acidified Sodium Hypochlorite for Antisepsis and Disinfection Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 53-55	Quality Control Analytical Methods: Testing of Electrolytes Solutions Author(s): Vu Nicole
Jan/Feb 2009 Pg. 56-62	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2008 Pg. 524-528	Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Author(s): Trissel Lawrence A
Nov/Dec 2008 Pg. 542	Glycerin, Sterile Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 530-536	Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Author(s): Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr
Sep/Oct 2008 Pg. 440-443	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2008 Pg. 344-353	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2008 Pg. 321-327	Microbial Air-Sampling Equipment, Part 2: Experiences of Compounding Pharmacists Author(s): Mixon Bill, Cabaleiro Joe, Latta Kenneth S, Vail Jane
May/Jun 2008 Pg. 252-257	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2008 Pg. 216-229	Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Author(s): Kastango Eric S
May/Jun 2008 Pg. 200-207	Dilution and Compounding of Ziconotide for Intrathecal Administration Author(s): Buchta Tony, Fakata Keri, Stuart William
Mar/Apr 2008 Pg. 130-135	Quality-Control Analytical Methods: Minimizing the Probability of Out-of-Specification Preparations: Results that Make You Say…Hmmm! Author(s): Odegard Russell D
Mar/Apr 2008 Pg. 136-144	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2008 Pg. 54-60	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2007 Pg. 450-470	Achievement of USP Chapter <797> Compliance by a 35-Bed Rural Hospital: A Case Study Author(s): Peters Gregory F, McKeon Marghi R, Nerbun Richard G
Nov/Dec 2007 Pg. 492-499	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2007 Pg. 500-501	Calculations: High-Technology Compounding and Investigational Dispensing Author(s): Webb Sheldon D, Stockton Shelly J
Nov/Dec 2007 Pg. 502-503	Standard Operating Procedure: Vial Crimper--Use, Care, Cleaning, and Maintenance Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 400-403	Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests Author(s): Kupiec Thomas C
Sep/Oct 2007 Pg. 404-410	Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2007 Pg. 328	Fentanyl 50-mg/mL in 0.9% Sodium Chloride Solution Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 302-305	Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Okeke Claudia C
Jul/Aug 2007 Pg. 314-323	Basics of Compounding: The Responsibilities of Compounding Personnel in Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 2 Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2007 Pg. 335	Sufentanil 50-mg/mL in 0.9% Sodium Chloride Solution Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 230-236	Basics of Compounding for the Implementation of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 1 Author(s): Allen Loyd V Jr, Okeke Claudia C
Jan/Feb 2007 Pg. 52-55	Quality Control Analytical Methods: The Quality of Sterility Testing Author(s): McGuire Jason, Kupiec Thomas C
Nov/Dec 2006 Pg. 428-433	BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Author(s): Benischek Rita L
Sep/Oct 2006 Pg. 372-375	Quality-Control Analytical Methods: Sterility Failure Investigations Author(s): Venti Eden M
Jul/Aug 2006 Pg. 277-280	Teaching Lab Renovation: University of Texas at Austin College of Pharmacy Combines Sterile and Nonsterile Compounding Lab Spaces Author(s): Acosta W Renee, Salzman Robert D
Jul/Aug 2006 Pg. 281-284	Quality Control Analytical Methods: A Guide to Quality Control Testing for the Compounding Pharmacist Author(s): Zolner William J
Jul/Aug 2006 Pg. 293-295	Aseptic Compounding in New Zealand and the Use of Still Air Boxes Author(s): Gargiulo Derryn, Kairuz Therese Eileen
Jul/Aug 2006 Pg. 253-261	Training and Competency Considerations for Pharmacies Providing Compounded Sterile Preparations Author(s): Douglass Kate
Jul/Aug 2006 Pg. 263-268	Putting the Science Back into the "Art and Science" of Compounding Author(s): Kastango Eric S
May/Jun 2006 Pg. 165-171	Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate Author(s): Reed-Kane Dana, Kirshbaum Karen
May/Jun 2006 Pg. 172	Case Report: Hydroxyprogesterone Caproate Injection for Prevention of Preterm Labor Author(s): Fields Shannon W
May/Jun 2006 Pg. 202-204	Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns? Author(s): Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2006 Pg. 218	Standard Operating Procedure: Sterility Test for Ophthalmic Solutions Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 208-211	Controlled Environment Testing Association Applications Guide for the Use of Barrier Isolators in Compounding Sterile Preparations in Healthcare Facilities, Part 2 Author(s): Wagner James T
Mar/Apr 2006 Pg. 113-119	Is Your Cleanroom Clean? An In-depth Look at Cleaning and Disinfecting Agents, Procedures, and Requirements for the Compounding Pharmacist Author(s): Jeffrey Megan
Jan/Feb 2006 Pg. 36-39	Basics of Compounding: Application of the United States Pharmacopeia Bacterial Endotoxins Test to Compounded Sterile Preparations Author(s): Dawson Michael F
Jan/Feb 2006 Pg. 46-49	How'd They Do That? Author(s): Roberts Jerrod L
Jan/Feb 2006 Pg. 69-73	Stability of Morphine Sulfate in Polypropylene Infusion Bags for Use in Patient-Controlled Analgesia Pumps for Postoperative Pain Management Author(s): Nguyen-Xuan Tho, Griffiths William, Kern Christian, Van Gessel Elisabeth, Bonnabry Pascal
Sep/Oct 2005 Pg. 390	Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 394	Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 395	Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 127-130	Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Newton David W
Mar/Apr 2005 Pg. 167	PostScription: Experts Everywhere Author(s): Rahe Hank
Jan/Feb 2005 Pg. 11-13	USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing Author(s): Caputo Ross A, Huffman Anne, Reich Robert
Jan/Feb 2005 Pg. 15-21	Using ACDs in the Practice of Pharmacy Author(s): Kastango Eric S
Jan/Feb 2005 Pg. 23-28	USP Chapter <797> and Preparing for a JCAHO Survey Author(s): McElhiney Linda F
Jan/Feb 2005 Pg. 29-31	Questions and Answers: USP Chapter <797> and JCAHO Compliance Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 33-35	A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In? Author(s): Vandenbroucke Johan, Rahe Hank
Jan/Feb 2005 Pg. 47-49	Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations Author(s): Kupiec Thomas C
Jan/Feb 2005 Pg. 53-56	Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? Author(s): Rahe Hank
Nov/Dec 2004 Pg. 466-467	Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 468	Calculations Author(s): Prince Shelly J
Nov/Dec 2004 Pg. 479-485	Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations Author(s): Allen Loyd V Jr
Sep/Oct 2004 Pg. 393-397	Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating Author(s): Kastango Eric S
Jul/Aug 2004 Pg. 242	PreScription - Categories of Pharmaceutial Compounding Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 251-263	A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Author(s): Newton David W, Trissel Lawrence A
May/Jun 2004 Pg. 216	Clonidine HCl 1.5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 217	Fluorouracil 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 220	Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 222	Testosterone Propionate 100-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 228-230	Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Author(s): Xu Quanyun A, Trissel Lawrence A, Pham Lien
May/Jun 2004 Pg. 231-235	Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Author(s): Trissel Lawrence A, Zhang Yanping
May/Jun 2004 Pg. 236-239	Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Author(s): Musami Patrick, Stewart James T, Taylor E Will
Mar/Apr 2004 Pg. 89-94	Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Author(s): Rahe Hank
Mar/Apr 2004 Pg. 138	Netilmicin 0.455% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 139	Pyridoxine HCl 100-mg/mL Injection, Preservative Free Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 153-155	Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Author(s): Gupta Vishnu D
Mar/Apr 2004 Pg. 156-159	Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Author(s): Lebrun John, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence M
Mar/Apr 2004 Pg. 160	PostScription: Cleanroom Standards Author(s): Fitzpatrick Mike, Goldstein Ken
Jan/Feb 2004 Pg. 54	Glycerin 50% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 55	Hydrochloric Acid 0.1-N Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 57	Phenol 5%-in-Oil Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 60	Vancomycin HCl and Heparin Sodium Injection Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 73-76	Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Author(s): Musami Patrick, Stewart James T, Taylor E Will
Jul/Aug 2003 Pg. 281-285	Containment of Hazardous Particulates in the Compounding Pharmacy Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 230-232	Stability of Amikacin Sulfate in AutoDose Infusion System Bags Author(s): Zhang Yanping, Trissel Lawrence A
Mar/Apr 2003 Pg. 114-116	Autoclaves for the Sterilization of Compounded Parenteral Products Author(s): Rahe Hank
Jan/Feb 2003 Pg. 42-43	Technology Spotlight: Barrier Isolators Author(s): Moussa Magdy, Rahe Hank, Lo Katharine
Nov/Dec 2002 Pg. 408-409 View Sample	Comparison of Endotoxin Testing Methods for Pharmaceutical Products Author(s): Joiner Timothy J, Kraus Paul F, Kupiec Thomas C
Nov/Dec 2002 Pg. 414	Book Review: Sterile Compounding Author(s): Reed-Kane Dana
Nov/Dec 2002 Pg. 415-417	Sterile Compounding of Respiratory Inhalation Solutions Author(s): Roberts Rob, Moore Eddie
Nov/Dec 2002 Pg. 448	Benzalkonium Chloride 1:750 Solution for Cold Disinfection Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 453	Furosemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 457	Phenobarbital Sodium 130-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 466-467	Cleaning and Disinfection Author(s): Allen Loyd V Jr
Mar/Apr 2002 Pg. 140-141	Sterilization of Talc for Use in Pleurodesis Author(s): Fehr Richard, Henke Michelle, Ashworth Lisa D
Jan/Feb 2002 Pg. 55-57	New Perspectives on Vancomycin Use in Home Care, Part 2: Delivery Systems Author(s): Kastango Eric S, Hadaway Lynn
Nov/Dec 2001 Pg. 422-423	Barrier Isolators: A New, High-tech Option for the Preparation of Sterile Admixtures Author(s): Karolchyk Scott
Nov/Dec 2001 Pg. 455	Sufentanil 25-mcg/mL, Bupivacaine 1-mg/mL Intrathecal Solution Author(s): Allen Loyd V Jr
Nov/Dec 2001 Pg. 465-469	New Perspectives on Vancomycin Use in Home Care, Part 1 Author(s): Kastango Eric S, Hadaway Lynn
Nov/Dec 2001 Pg. 476-479	Cross-contamination in Porcelain Mortars Author(s): Bauer-Brandl Annette, Falck Astrid, Ingebrigtsen Lars, Nilsen Cathrina
Jul/Aug 2001 Pg. 246-253	Quality Assurance for Sterile Products Author(s): Kastango Eric S, Douglass Kate
Jul/Aug 2001 Pg. 254-258	Sterile Compounding with Barrier-Isolation Technology Author(s): Rahe Hank
Jul/Aug 2001 Pg. 259-263	Bacterial Endotoxins and Pyrogens Author(s): Jones Marty
Jul/Aug 2001 Pg. 265-267	Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices" Author(s): Okeke Claudia C, Barletta Frank, Newton David W, Allen Loyd V Jr
Jul/Aug 2001 Pg. 278-279	Sterile Compounding: Excerpts from the Reviews of Current Published Literature Author(s): MacCara Mary E
Jul/Aug 2001 Pg. 284-286	Analytical Testing Facilities and Products Author(s): Hudson Sonora
Jul/Aug 2001 Pg. 313	Maintenance of the Cleanroom Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 59-63	Sterile-Product Preparations: Mix or Buy? Author(s): Kastango Eric S
Jul/Aug 2000 Pg. 280	Short Communication: Compounding for Implantable Pumps Author(s): Molitor Richard
May/Jun 2000 Pg. 223-224	Dry Heat Sterilization of Parenteral Oil Vehicles Author(s): Kupiec Thomas C, Matthews Parrish, Ahmad Riaz
Jan/Feb 2000 Pg. 24-25	Compounding Intrathecal Medications Author(s): Vidrine Eric
Sep/Oct 1999 Pg. 406-407	Standard Operating Procedure: Quality Assessment for Injectable Solutions Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 253-258	Improving the Management, Operations and Cost Effectiveness of Sterile-Product Compounding Author(s): Kastango Eric S, Douglass Kate
Jul/Aug 1999 Pg. 263-269	Sterilization and Depyrogenation Principles and Methods Author(s): Akers Michael J
Jul/Aug 1999 Pg. 270-273	Sterile Product Compounding: A Comparison of ASHP and USP Guidelines Author(s): Lima Hetty A
Jan/Feb 1999 Pg. 64-66	Y-Site Stability of Fosphenytoin and Sodium Phenobarbital Author(s): English Brett A, Riggs Robert M, Webster Andrew A, Benner Kimberly W
Sep/Oct 1998 Pg. 379	Testing for Bacterial Endotoxins Author(s): Jelinek Todd
May/Jun 1998 Pg. 189	Ophthalmic Compounding: Techniques for Achieving Sterility Author(s): Leiter Charles W
May/Jun 1998 Pg. 192-195	Preservation, Sterilization, and Sterility Testing of Ophthalmic Preparations Author(s): Allen Loyd V Jr
May/Jun 1998 Pg. 214-215	An Automated Process for Batch Preparation of Epidural Solutions Containing Bupivacaine Hydrochloride and Fentanyl Citrate Author(s): Rice Stephen P
May/Jun 1998 Pg. 242	General Aseptic Procedures Used at a Laminar Airflow Workbench Author(s): Allen Loyd V Jr